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Edited by Vladimir SkulachevAbstract This study was undertaken to characterize the
consequences of Ral-interacting protein (RLIP76)-loss with re-
spect to drug resistance, transport, radiation resistance, and
alternative transport mechanisms in mouse embryonic ﬁbroblasts
(MEFs). MEFs were derived from RLIP76+/+, RLIP76+/ and
RLIP76/ mice. The transport of doxorubicin (DOX), colchi-
cine (COL), leukotriene C4 and dinitrophenyl S-glutathione
(DNP-SG) was analyzed in inside-out vesicles (IOVs) prepared
from MEFs. We used immuno-titration of transport activity to
determine the contribution of RLIP76, MRP1, and p-glycopro-
tein (Pgp) towards total transport activity. Loss of RLIP76
alleles resulted in signiﬁcant sensitization to radiation, DOX,
cisplatin, and vinorelbine (VRL). In IOVs prepared from MEFs,
we observed a stepwise loss of transport activity. Loss of
RLIP76 confers sensitivity to xenobiotics and radiation due to
the loss of a common transport mechanism for glutathione–
electrophile conjugates and xenobiotics.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Chain reaction of lipid-peroxidation is an obligate common
chemical reaction triggered by both oxidant and radiant stress
[1–3]. These stressors can directly generate the OH radical
which initiate lipid-peroxidation and formation of lipid-peroxy
radicals, which have suﬃciently long half-lives to allow diﬀu-
sion to the nucleus, and suﬃciently reactive to cause direct
DNA scission [4]. Electrophilic alkenals, such as 4-hydroxy-
nonenal (4HNE), represent down-stream lower energy by-
products of lipid-peroxidation which are known to induce
stress-resistance mechanisms at low concentrations, and apop-Abbreviations: RLIP76 (RalBP1), Ral-interacting protein; GSH, glu-
tathione; GS-E, glutathione–electrophile conjugates; DNP-SG, dini-
trophenyl S-glutathione; COL, colchicine; DOX, doxorubicin; 4HNE,
4-hydroxynonenal; IOVs, inside-out vesicles; LTC4, leukotriene C4;
MEFs, mouse embryonic ﬁbroblasts; MRP, multi-drug resistance
associated protein; Pgp, p-glycoprotein; VRL, vinorelbine; RLIP76+/+,
wild-type; RLIP76+/, heterozygous; RLIP76/, homozygous
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unsaturated alkenals react with glutathione (GSH) to form
Michael-adducts, a reversible reaction in presence of the cata-
lyst glutathione S-transferases (GST). The further biotransfor-
mation of the thioether conjugate to mercapturate requires
eﬄux from cells to be further metabolized by c-glutamyl trans-
peptidase which is present on the outer leaﬂet of plasma mem-
branes. Because glutathione–electrophile conjugates (GS-E)
are potent product inhibitors of GST, the removal of these
products is also necessary to maintain GST-activity defending
against foreign electrophilic toxins (xenobiotic) [5]. This model
predicts that depletion of GS-E eﬄux capacity should inhibit
phase II biotransformation. Our earlier descriptions of the
existence of a single transporter protein which could mediate
competing transport of acidic GS-E (products of phase II bio-
transformation) and weakly basic amphiphilic drugs such as
doxorubicin (DOX) (substrates of phase I biotransformation)
suggested the intriguing possibility that such a mechanism
would be in the unique position of regulating biotransforma-
tion at both ends-regulating levels of substrates of phase I bio-
transformation, and products of phase II biotransformation.
We have subsequently shown that Ral-interacting protein
(RLIP76) is the predominant mechanism mediating the shared
transport of xenobiotic as well as GS-E [6–13].
RLIP76, the ﬁrst known eﬀector of Ral, is a 76-kDa multi-
functional ATPase that couples the movement of substances
with ATP-hydrolysis. It is found throughout the cell, in mem-
brane, cytosol and the nucleus, and is known to shift between
these compartments in response to stress. It is a component of
important multi-functional protein complexes including the
mitotic spindle, the receptor signaling complexes for EGF,
TGF-b, insulin, and clathrin-dependent endocytosis [14–16].
We have shown that RLIP76 is a stress-protective multi-spe-
ciﬁc transporter of chemotherapeutic agents and GS-E [6–
10]. Mouse embryonic ﬁbroblasts (MEFs) were derived from
RLIP76+/+ (wild-type), RLIP76+/ (hetero) and RLIP76/
(homozygous) mice and to characterize the consequences of
RLIP76 loss with respect to drug resistance, transport mecha-
nism and radiation resistance in MEF model. This model pre-
dicted that sensitivity to stressor such as radiation, oxidants,
and xenobiotic metabolized through glutathionylation should
be increased in animals lacking RLIP76. The eﬀect of RLIP76
loss on the transport of several model substrates including,
physiologic and pharmacologic GS-E, and chemotherapeutic
drugs such as DOX and colchicine (COL), and the relative
contributions of RLIP76 and other known eﬄux pumpsblished by Elsevier B.V. All rights reserved.
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protein (MRP)) in the transport of these substrates were also
examined in an MEF model.2. Materials and methods
2.1. Animal studies
Animal studies were performed as approved by the IACUC in the
institutional animal care facility. Colonies of RLIP76+/+, RLIP76+/
and RLIP76/ animals have been bred according to IACUC proto-
col.
2.2. Materials
DOX and COL were obtained from Adria Laboratories (Columbus,
OH) and Bedford Laboratories (Bedford, OH), respectively. Melpha-
lan, busulfan and cyclophosphamide were procured from Sigma (St.
Louis, MO). 14C-DOX (speciﬁc activity 54 mCi/mmol), 3H-LTC4 (spe-
ciﬁc activity 140 Ci/mmol) and 3H-COL (speciﬁc activity 70 Ci/mmol)
were purchased from NEN Life Sciences (Boston, MA). Polyclonal
rabbit-anti-human-RLIP76 IgG were prepared and puriﬁed as de-
scribed earlier [6] whereas antibodies against MRP1 (N-19) and Pgp
(C-19) were purchased from Santa-Cruz Biotechnology (Santa Cruz,
CA). Dinitrophenyl S-glutathione (DNP-SG) was synthesized from
CDNB and GSH according to the method described by us [6].
2.3. Method for preparing mouse embryonic ﬁbroblast cultures
Twelve weeks old C57BL/6 mice born of heterozygous · heterozy-
gous mating were genotyped by PCR strategy on mouse tail DNA
using forward, reverse and long terminal region primers. These mice
were commissioned from Lexicon Genetics. Embryo ﬁbroblast lines
were prepared from RLIP76+/+, RLIP76+/, RLIP76/ mice on the
13th or 14th day of pregnancy [17].
2.4. Preparation of RLIP76-liposomes
Recombinant human RLIP76 was puriﬁed as previously described.
Purity was checked by Western-blot analysis, and MALDI-MS. Puri-
ﬁed protein was reconstituted into artiﬁcial asolectin–cholesterol lipo-
somes [6].
2.5. Transport of 14C-DOX, 3H-COL, 3H-DNP-SG and 3H-LTC4
Inside-out vesicles (IOV) were prepared fromRLIP76+/+, RLIP76+/,
RLIP76/MEFs and transport studies in IOV were performed as de-
scribed previously [18]. ATP-dependent uptake of 14C-DOX (speciﬁc
activity 8.5 · 104 cpm/nmol), 3H-COL (speciﬁc activity 1.4 · 104
cpm/nmol), 3H-DNP-SG (speciﬁc activity 3.6 · 103 cpm/nmol), and
3H-LTC4 (speciﬁc activity 1.6 · 103 cpm/pmol), were determinedby sub-
tracting the radio-activity (cpm) of the controlwithoutATP from that of
the experimental containing ATP, and the transport rate was calculated
in terms of pmol/min/mg protein. In one of the controls, IOV was ex-
cluded while the other control was incubated with an equal amount of
heat-inactivated IOV. Each determination was performed in triplicate.
2.6. Transport in vesicles coated with antibodies
IOV (20 lg protein/30 ll reaction mixture) were incubated sepa-
rately with 1 lg of each anti-RLIP76, anti-MRP1, and anti-Pgp anti-
bodies for 30 min at room temperature. In one of the controls, IgG
was excluded while the other control was treated with an equal amount
of pre-immune IgG. After incubation, the ATP-dependent transport of
14C-DOX, 3H-COL, 3H-DNP-SG, and 3H-LTC4 in IOV coated with
diﬀerent antibodies were measured [19].
2.7. Drug sensitivity assay
Cell density measurements were performed using a hemocytometer
to count reproductive cells resistant to staining with trypan blue.
Approximately 20000 cells were seeded into each well of 96-well plates
containing 160 ll medium. Post 24 h incubation, 40 ll aliquots of drug
concentrations ranging from 0.1 nm to 10000 nm was then added to
eight replicate wells to assess the IC50 of drug. After 96 h incubation,
20 ll of 5 mg/ml MTT was introduced to each well and incubated
for 2 h. The plates were centrifuged and cells were subsequently dis-solved in 100 ll DMSO with gentle shaking for 2 h at room tempera-
ture, followed by measurement of OD at 570 nm [8].
2.8. Eﬀect of RLIP76-liposomes on 14C-DOX accumulation and eﬄux
Drug accumulation and eﬄux studies were performed in RLIP76+/+,
RLIP76/ and RLIP76-liposomes (40 lg/ml) treated RLIP76/
MEFs, according to the protocol described by us [8].
2.9. Colony-forming assay
MEFs (0.1 · 106 cells/500 ll) were irradiated at 0 (no radiation), 100,
200, 500 and 1000 cGY (6 · 106 V-photon/min) for 1.25 min at the
Texas Cancer Center, Arlington, TX, then aliquots of 50 and 100 ll
in 60-mm Petri dishes, separately, in a total volume of 4 ml by adding
medium. After 10 days, un-irradiated and irradiated cells were stained
with methylene blue for 30 min, and colonies were counted using an
Innotech Alpha-Imager HP [13].
2.10. Eﬀect of oxidative-stress on RLIP76 expression
MEFs were treated with either 50 lM H2O2 or 25 mM glucose for
20 min at 37 C followed by washing with PBS, resuspended in the
medium and was allowed to recover for 2 h. Cells were solubilized in
lysis buﬀer and centrifuged at 105000 · g for 1 h at 4 C and the super-
natant was collected. One hundred micrograms of proteins were sub-
jected to SDS–PAGE followed by Western-blot analyses using anti-
RLIP76 IgG.
2.11. Statistical methods
The Kaplan Meier method was used to create the survival curves for
chemotherapy. All data were evaluated with a two-tailed unpaired Stu-
dents t-test or compared by one-way ANOVA and are expressed as
the mean ± S.D. A value of P < 0.05 was considered statistically signif-
icant3. Results and discussion
3.1. MEF model system
Western-blot analyses of crude membrane extracts from
RLIP76+/+, RLIP76+/ and RLIP76/MEFs were performed
against anti-RLIP76 IgG (Fig. 1A). A single protein band was
seen at 95 kDa in homogenate of RLIP76+/+ and RLIP76+/
MEF, with the amount of protein in the heterozygous knock-
out approximately half of that in wild-type. No RLIP76-cross-
reactive protein was found in RLIP76/ MEFs, consistent
with their homozygous gene disruption (Fig. 1A, lane 4). Wes-
tern-blot analyses of RLIP76/ MEFs were also performed
after RLIP76-liposomal delivery by incubating the cells with
40 lg/ml RLIP76-liposomes, indicating detectable level of
RLIP76 (Fig. 1A, lane 5). These results conﬁrm that the
MEF model system has the expected three levels of RLIP76
protein, and no other immuno-logically related proteins, and
also prove that RLIP76-liposomes can be used to replenish
RLIP76 in RLIP76/ MEFs.3.2. Transient oxidative-stress causes increased insulin-
rhodamine quantum dots endocytosis
We have previously shown that a rapid induction of RLIP76
occurs in cells exposed to mild transient oxidative-stress and
these cells transport GS-E at a several-fold faster rate in order
to protect themselves from the toxicity of the electrophilic
products of lipid-peroxidation [20]. Reasoning that transient
oxidative-stress could also aﬀect RLIP76-mediated endocyto-
sis, we examined the insulin: quantum dots endocytosis in
RLIP76+/+ MEF subjected to mild oxidative-stress. Results
of these experiments clearly demonstrate that after a brief
exposure to 50 lM H2O2 (oxidant stress) or 25 mM glucose
Fig. 1. RLIP76-expression in MEFs. Aliquots of crude membrane fraction from RLIP76+/+, RLIP76+/, RLIP76/, and RLIP76/MEFs treated
with RLIP76-liposomes (lanes 2–5, respectively), containing 200 lg protein were applied in Western-blot analyses against anti-RLIP76 IgG as the
primary antibody followed by peroxidase-conjugated goat-anti-rabbit-IgG as a secondary antibody (panel A). In panel B, Western-blot for RLIP76
were performed on RLIP76+/+ MEFs (lane 2), treated with 50 lM H2O2 (lane 3) and 25 mM glucose (lane 4). Aliquots of 100 lg crude membrane
fraction were loaded in SDS–PAGE, transblotted, and probed using anti-RLIP76 IgG as a primary and peroxidase-conjugated goat-anti-rabbit IgG
as a secondary antibody (panel B). The blots were developed with 4-chloro-1-napthol as chromogenic substrate and developed bands were quantiﬁed
by scanning densitometry. b-Actin expression was used as loading control. Insulin-rhodamine quantum dots (QD) using Confocal laser microscopy
RLIP76+/+ and RLIP76/ MEFs (0.1 · 106 cells/ml) were grown on cover slips, followed by incubation with either 50 lM H2O2 or 25 mM glucose
for 20 min at 37 C, and allowed to recover for 2 h. Cells were treated with 10% goat serum for 30 min and labeled with molar ratio 6:1 of insulin:QD
on ice for 45 min, washed and incubated for 10 min at 37 C and ﬁxed in cold 4% paraformaldehyde. Slides were analyzed using confocal laser-
scanning microscopy (panel C).
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receptor (Fig. 1C) along with marked induction of RLIP76-
expression (2.7-fold by H2O2 and 1.9-fold by glucose;
Fig. 1B, lanes 3 and 4, respectively). These ﬁndings are consis-
tent with the hypothesis that RLIP76-mediated GS-E trans-
port is crucial to the regulation of endocytosis and strong
evidence for vital role of RLIP76 in receptor–ligand endocyto-
sis and may explain the mechanism for transient glucose intol-
erance caused by stress. We also conﬁrmed that RLIP76/
mice are insulin-sensitive which are accounted for by both in-
creased insulin-mediated suppression of hepatic glucose output
(HGO) and increased peripheral glucose uptake and the ratio
of plasma insulin/glucose was found to be lowest in RLIP76/
mice (S.S. Singhal, unpublished observations).
3.3. RLIP76 loss increases toxicity of anthracycline and
alkylating agents in mice
Recently, we have shown that RLIP76/ mice were signiﬁ-
cantly more sensitive to radiation as compared with RLIP76+/+.
The LD50 for RLIP76
+/+ mice was between 200 and 300 cGy,
and that for RLIP76/mice was between 50 and 100 cGy indi-
cating a dose-modiﬁcation factor between 3 and 4. Administra-
tion of 200 lg RLIP76-liposomes at a single dose was
administered 14 h after radiation, we observed a remarkable
improvement in survival of RLIP76/ animals [9,21].
We have previously demonstrated that about 80% activity
for DOX-transport in the tissues of RLIP76/ mice was
abrogated, suggesting RLIP76 to be the major transporterof this non-alkylating drug also [16]. Present studies showed
that the RLIP76/ mice had signiﬁcantly shorter survival
as compared with RLIP76+/+ mice when treated with identical
doses of DOX (P < 0.01). A similar pattern was observed
when the mice were treated with the classical alkylating
agents, melphalan (P < 0.05) and busulfan (P < 0.05). For
cyclophosphamide (P < 0.07), the diﬀerence did not reach sta-
tistical signiﬁcance (Fig. 2). The diﬀerence in the sensitivity of
drugs between RLIP76/ and RLIP76+/+ mice was more
prominent with DOX, in which all animals died within 13
days in RLIP76/ group as compared to 35 days for
RLIP76+/+ group. Taken together, these studies demonstrate
a signiﬁcantly greater sensitivity to the toxic eﬀects of radia-
tion and alkylating agents as well as anthracycline chemother-
apy drugs caused by loss of RLIP76, and indicate that the
impairment of RLIP76-mediated transport of GS-E and
DOX in RLIP76/ mice leads to increased sensitivity not
only to radiation but also to the widely used chemotherapeu-
tic agents.
3.4. Eﬀect of RLIP76 loss on radiation-sensitivity
X-irradiation sensitivity of the MEFs was tested in dose–re-
sponse studies utilizing 100–1000 cGy single dose X-irradia-
tion, followed by colony-forming assays. The colony-forming
activity of the RLIP76+/ and RLIP76/ was lower than
RLIP76+/+ (84% and 73%, respectively). Normalized to respec-
tive un-irradiated controls, at all radiation levels, the RLIP76+/+
MEFS were least sensitive to radiation (Fig. 3). Results shown
Fig. 2. RLIP76 loss sensitizes to chemotherapy toxicity in mice. The
experiment had a 2 · 4 factorial design (genotype · drugs) with three
animals per group. C57 black mice, conﬁrmed as having either
RLIP76+/+ (circles) or RLIP76/ (diamonds) genotyped as previously
described [9], were weighed and randomized to treatment with a single
i.p. injection of PBS containing either DOX (11.1 mg/kg b.w.), P <
0.01, when compared RLIP76+/+ vs. RLIP76/; melphalan (6 mg/kg
b.w.), P < 0.05, when compared RLIP76+/+ vs. RLIP76/; busulfan
(86 mg/kg b.w.), P < 0.05, when compared RLIP76+/+ vs. RLIP76/
or cyclophosphamide (159 mg/kg b.w.) P < 0.07, when compared
RLIP76+/+ vs. RLIP76/. Animals were monitored twice daily for
survival.
Fig. 3. Radiation-sensitization by loss of RLIP76. RLIP76+/+ (black
bar), RLIP76+/ (cross-hatched bar) and RLIP76/ (gray bar) MEFs
(0.1 · 106 cells/500 ll in triplicates) were irradiated at 0 (no radiation),
100, 200, 500, and 1000 cGY (6 · 106 V-photon/min) for 1.25 min then
aliquots 50 and 100 ll in 60 mm Petri dishes, separately, in a total
volume of 4 ml medium. After 10 days, un-irradiated and irradiated
cells were stained with methylene blue for 30 min than colonies were
counted using an Innotech Alpha-Imager HP [13]. The results of
colony-forming assays of radiated cells are shown normalized to the
respective un-irradiated controls. Plating eﬃciency of RLIP76+/ and
RLIP76/ MEFs was 84% and 73%, respectively, as compared to
RLIP76+/+ MEF. Values are means ± S.D. of three experiments.
Statistical analyses by ANOVA were signiﬁcant at P < 0.05 for
RLIP76+/+ vs. RLIP76+/, RLIP76+/+ vs. RLIP76/, and RLIP76+/
vs. RLIP76/ at 200, 500, and 1000 cGY.
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followed by RLIP76+/, and then RLIP76/.
3.5. Eﬀect of RLIP76 loss on sensitivity to chemotherapy
Since RLIP76 is a very broad-speciﬁcity transporter that in
addition to GS-E, is an eﬃcient transporter of chemotherapy
drugs, and because RLIP76/ mice are more sensitive to che-
motherapy agents such as the GS-E forming alkylating agents
(cyclophosphamide, busulfan, and melphalan) as well as DOX,
we expected that MEFs with loss of RLIP76 should also be
sensitized to chemotherapy drugs.
Therefore, the sensitivity of RLIP76+/+, RLIP76+/, and
RLIP76/ MEFs towards the anthracycline drug (DOX),
the vinca alkaloid (vinorelbine (VRL)) and the platinum coor-
dinate cisplatin (a GS-E forming drug) were compared using
an MTT cytotoxicity assay [8]. Results of these studies clearly
demonstrated a stepwise loss in drug resistance to all three
classes of chemotherapy drugs with loss or RLIP76 alleles (Ta-
ble 1) conﬁrming the result of whole-animals studies [9,21].
3.6. Eﬀect of RLIP76 loss on transport activity for xenobiotic
and GS-E
Anthracyclines and vinca alkaloids (VRL and COL) have
been shown previously to be transported by RLIP76 [8,22].
To determine whether increased drug sensitivity of RLIP76/
was indeed due to loss of transport function, we compared
ATP-dependent transport of DOX, COL and two representa-
tive GS-E (LTC4 and DNP-SG) in IOVs prepared fromMEFs.
A stepwise loss, more prominent when compared between 2 vs.
1 allele, was seen in transport activity of all three drugs (Fig. 4
and Table 2). Remarkably, over 80% of the transport activity
for all these compounds was absent in RLIP76/MEFs, indi-
cating that RLIP76 is the major transporter of anthracyclines,
vinca alkaloids and GS-Es. Transport activity in IOVs pre-
pared from RLIP76/ MEFs were also performed after
RLIP76-liposomal delivery by incubating RLIP76/ MEFs
with 40 lg/ml RLIP76-liposomes, showed transport activity
with all the substrates were comparable to RLIP76+/+ (Table
2).
3.7. Relative contributions to transport activity
To evaluate the relative role of various transporters for these
substrates, we performed immuno-titration studies using
anti-RLIP76, anti-Pgp and anti-MRP antibodies. In previous
studies, we have demonstrated stringently the lack ofTable 1
IC50 values in MEFs
MEFs IC50(nM)
Vinorelbine Cisplatin Doxorubicin
RLIP76+/+ 2.2 ± 0.31 1520 ± 180 110 ± 20
RLIP76+/ 1.3 ± 0.15 830 ± 110 42 ± 8
RLIP76/ 0.4 ± 0.03 360 ± 50 23 ± 3
RLIP76-liposomes
treated RLIP76/
1.8 ± 0.22 1270 ± 185 86 ± 11
Drug sensitivity assays were performed using MTT (at 96 h) to
determine IC50 values [23]. The values are presented as mean ± S.D.
from three separate determinations with eight replicates each (n = 24).
Statistical analyses by ANOVA were signiﬁcant at P < 0.01 for
RLIP76+/+ vs. RLIP76+/, RLIP76+/+ vs. RLIP76/, RLIP76+/ vs.
RLIP76/ and RLIP76/ vs. RLIP76-proteoliposomes treated
RLIP76/.
Fig. 4. Loss of transport of anthracycline, vinca alkaloid, and GS-E with loss of RLIP76. IOVs from the membranes of RLIP76+/+, RLIP76+/,
RLIP76/MEFs were prepared [18]. IOVs protein from each MEF (20 lg) was coated separately with buﬀer alone (white bar), pre-immune-serum
(gray bar), anti-RLIP76 IgG (cross-hatched bar), anti-MRP1 IgG (horizontal line bar) and anti-Pgp IgG (dotted bar) and incubated for 30 min at
room temperature. Uptake of 14C-DOX (panel A), 3H-COL (panel B), 3H-LTC4 (panel C) or
3H-DNP-SG (panel D) in IOVs coated separately with
diﬀerent antibodies was measured [19]. Heat-inactivated IOVs protein (70 C · 5 min) was also used for additional control (black bar). For all panels,
data represent mean ± S.D. of three separate experiments done in triplicate. Statistical analyses by ANOVA were signiﬁcant at p < 0.01 for RLIP76+/+
vs. RLIP76+/, RLIP76+/+ vs. RLIP76/, and RLIP76+/ vs. RLIP76/.
Table 2
Xenobiotic and GS-E transport activity in MEFs
MEFs Transport activity (pmol/min/mg protein)
3H-COL 14C-DOX 3H-DNP-SG 3H-LTC4
RLIP76+/+ 587 ± 52 196 ± 23 1058 ± 87 19.1 ± 2.2
RLIP76+/ 238 ± 34 71 ± 9 361 ± 28 7.2 ± 1
RLIP76/ 91 ± 14 25 ± 3 129 ± 15 2.1 ± 0.3
RLIP76-liposomes
treated RLIP76/
488 ± 38 170 ± 12 861 ± 66 17.7 ± 1.5
Eﬀect of RLIP76 genotype on 14C-DOX, 3H-COL, 3H-DNP-SG and
3H-LTC4 transport activity in IOVs prepared from each MEFs. Sta-
tistical analyses by ANOVA were signiﬁcant at P < 0.01 for RLIP76+/+
vs. RLIP76+/, RLIP76+/+ vs. RLIP76/, RLIP76+/ vs. RLIP76/
and RLIP76/ vs. RLIP76-proteoliposomes treated RLIP76/.
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of all three antibodies to precipitate out the respective antigens
to inhibit transport activity in IOVs [19]. In wild-type MEFs,
whereas anti-RLIP76 IgG precipitated out over 2/3 of total
transport activity for all four agents, anti-Pgp IgG did not af-
fect transport signiﬁcantly. Anti-MRP IgG precipitated out
about 1/3 of transport activity towards all four substrates in
wild-type MEFs, but over half of the residual activity in the
RLIP76+/ MEFs was precipitated out by these antibodies.
These ﬁndings suggested that MRP functions as a backup
mechanism upon RLIP76 loss. As expected, in the RLIP76/
MEFs, anti-RLIP76 IgG had no eﬀect on transport, whereas
anti-MRP IgG reduced the residual transport to about half.
The lack of eﬀect of anti-RLIP76 IgG in the homozygousknockout MEFs is indicative of the speciﬁcity of the antibod-
ies. Heat-inactivated vesicles had near complete loss of trans-
port, conﬁrming that the transport observed in present
conditions is due to a biological transporter rather than any
non-speciﬁc eﬀect of the assay (Fig. 4).
3.8. Eﬀect of RLIP76-liposomes on 14C-DOX accumulation and
eﬄux
The eﬀect of augmentation of RLIP76 on drug uptake/eﬄux,
transport and resistance were studied in MEFs. Cellular
RLIP76 was augmented by liposomal-delivery of puriﬁed
RLIP76, were analyzed for RLIP76 protein, cellular DOX up-
take/eﬄux, transport in IOV and DOX cytotoxicity. These re-
sults showed RLIP76-liposomes treated RLIP76/ MEF had
lower uptake and higher IC50 for DOX and greater transport
rate for DOX as well as GS-E. These ﬁndings clearly demon-
strate that augmentation of cellular RLIP76 confers a drug
accumulation deﬁcient phenotype due to increased eﬄux
(Fig. 5).
RLIP76 is a fundamental link between biochemical path-
ways of GSH-linked metabolism of xenobiotic and stress-de-
fense signaling pathways. It plays a central role in radiation
and chemotherapy resistance through its activity as a multi-
speciﬁc ATP-dependent transporter. Taken together, present
studies in MEFs, as well as previous studies in whole animals
[9,21] and cultured cells [17,21], have established a new para-
digm for oxidant/radiant stress protection mechanism by
RLIP76-liposomes delivery and have provided a sound mech-
anistic rationale for placing RLIP76 at a crucial position
among these defenses.
Fig. 5. Eﬀect of RLIP76-liposomes on 14C-DOX accumulation and
eﬄux in MEFs. The augmentation of RLIP76 by RLIP76-liposomes in
RLIP76/ MEFs was conﬁrmed by Western-blot using anti-RLIP76
IgG (see Fig. 1A). The rate of cellular accumulation and eﬄux of 14C-
DOX was evaluated using established methods [8]. All studies were
performed in triplicates, with means ± S.D. presented. RLIP76+/+
MEFs (¤); RLIP76/ MEFs (n); RLIP76-liposomes-treated
RLIP76/ MEFs (m). Statistical analyses by ANOVA were signiﬁ-
cant at P < 0.01 for RLIP76/ vs. RLIP76+/+ and RLIP76/ vs.
RLIP76-proteoliposomes treated RLIP76/.
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Studies presented in this communication demonstrate for the
ﬁrst time that loss of RLIP76 confers sensitivity to xenobiotic
and radiation due to the loss of a common transport mecha-
nism for both xenobiotic and glutathione conjugates (GS-E).
These ﬁnding are of fundamental signiﬁcance because they
provide evidence for a single target for enhancing chemother-
apy and radiation.
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